| Literature DB >> 27898629 |
Sharon G Humiston1, Thuylinh N Pham.
Abstract
During influenza season, acute respiratory illness due to influenza is difficult to distinguish from other influenza-like illnesses, but testing should be reserved for situations when timely results will influence management or infection control measures. Immunization status and timing of disease onset notwithstanding, a neuraminidase inhibitor should be offered immediately for certain high-risk children; neuraminidase inhibitor treatment should be considered if shorter illness is warranted or an at-risk sibling may be protected. Antipyretics and cough control may be useful. Immunization with an age-appropriate dose of an inactivated influenza vaccine is the cornerstone of prevention for health care personnel and our patients.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27898629 DOI: 10.1097/PEC.0000000000000974
Source DB: PubMed Journal: Pediatr Emerg Care ISSN: 0749-5161 Impact factor: 1.454